Digoxin toxicity: Difference between revisions
| Line 89: | Line 89: | ||
== Management == | == Management == | ||
''Calcium is theoretically contradindicated in Dig Toxicity (see [[Stone Heart]])'' | |||
*'''[[Digoxin Immune Fab]]''' | *'''[[Digoxin Immune Fab]]''' | ||
**Indications | **Indications | ||
| Line 99: | Line 99: | ||
*** Acute digoxin ingestions with post distribution digoxin >10ng/mL (by 6 hours post ingestion) | *** Acute digoxin ingestions with post distribution digoxin >10ng/mL (by 6 hours post ingestion) | ||
*** Chronic digoxin ingestion leading to steady state serum digoxin concentrations of >4ng/ml | *** Chronic digoxin ingestion leading to steady state serum digoxin concentrations of >4ng/ml | ||
*[[Activated Charcoal]] | *[[Activated Charcoal]] | ||
**Questionable efficacy | **Questionable efficacy | ||
Revision as of 12:16, 3 September 2015
Background
- Mechanism of action
- Positive inotropic effect
- Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca
- Increases vagal tone
- Can lead to bradyarrhythmias (esp in young)
- Increases automaticity
- Can lead to tachyarrhythmias (esp in elderly)
- Positive inotropic effect
- Renally cleared
- Hemodialysis does not work
- Can also be found in nature: Foxglove, Oleander, certain toads
Risk Factors
- Electrolyte Imbalance
- Hypovolemia
- Renal insufficiency
- Cardiac Ischemia
- Hypothyroidism
- Meds
- CCBs, amiodarone
Acute vs. Chronic
- Acute
- Lower mortality
- Bradycardia / AV block more common
- Younger patients
- Often don't need Fab
- Chronic
- Higher mortality
- Ventricular dysrhythmias more common
- Older patients
- Often need Fab therapy
Clinical Features
Cardiac
- Syncope
- Dysrhythmias
- PVCs
- Bradycardia
- SVT w/ AV block
- Junctional escape
- Ventricular dysrhythmia, including bidirectional V-tach (esp in chronic toxicity)
- Digitalis Effect (seen with therapeutic levels; not indicative of toxicity)
- T wave changes (flattening or inversion)
- QT interval shortening
- Scooped ST segments with depression in lateral leads
- Increased U-wave amplitude
GI
- Often the earliest manifestation of toxicity
Neuro
Differential Diagnosis
- Calcium channel blocker toxicity
- Beta blocker toxicity
- Clonidine toxicity
- Organophosphate toxicity
- Sick sinus syndrome
Diagnosis
Work-Up
- Digoxin level
- Only useful prior to administration of Fab (otherwise becomes falsely elevated)
- Chemistry
- Urine output
- ECG (serial)
Evaluation
- Must use H&P and labs in combination; no single element excludes or confirms the diagnosis
- Digoxin level
- Normal = 0.5-2 ng/mL (ideal = 0.7-1.1)
- May have toxicity even with "therapeutic" levels (especially with chronic toxicity)
- Measure at least 6hr after acute ingestion (if stable); immediately for chronic ingestion
- If measure before this may be falsely elevated due to incomplete drug distribution
- Normal = 0.5-2 ng/mL (ideal = 0.7-1.1)
- Potassium level
- Acute toxicity: Degree of Hyperkalemia correlates wwith degree of toxicity
- Chronic toxicity: K+ may be normal/low (concomitant diuretic use) or high (renal failure)
Management
Calcium is theoretically contradindicated in Dig Toxicity (see Stone Heart)
- Digoxin Immune Fab
- Indications
- Ventricular dysrhythmias
- Symptomatic bradycardias unresponsive to atropine
- Hyerkalemia >5.0 mEq/L secondary to digitalis intoxicaiton
- Coningestions of cardiotoxic drugs (beta-blockers, cyclic antidepressants)
- Acute digoxin ingestion of greater than 10mg in adults or greater than 4mg in children
- Acute digoxin ingestions with post distribution digoxin >10ng/mL (by 6 hours post ingestion)
- Chronic digoxin ingestion leading to steady state serum digoxin concentrations of >4ng/ml
- Indications
- Activated Charcoal
- Questionable efficacy
- Only an adjunctive tx; NOT an alternative to fab fragment therapy
- Consider only if present within 1 hr of ingestion
- 1g/kg (max 50g)
Dysrhythmias
- Digoxin Immune Fab is the agent of choice for all dysrhythmias!
- Cardioversion should only be used as a last resort (may precipitate V-Fib)
- Consider lower energy settings (25-50J)
- Bradyarrhythmias (symptomatic)
- Ventricular dysrhythmias
- Phenytoin
- Enhances AV conduction
- Phenytoin: 15-20mg/kg at 50mg/min
- Fosphenytoin: 15-20mg PE/kg at 100-150mg/min
- Lidocaine
- Decreases ventricular automaticity
- 1-3mg/kg over several minutes; follow by 1-4mg/min
- Magnesium
- Many patients have Hypomagnesemia and labs can be unreliable.
- 2-4 g IV over 20-60 mins
- Phenytoin
Hyperkalemia
- Treat with Fab, not with usual meds
- Once Fab is given hyperkalemia will rapidly correct
- If Fab unavailable and hyperkalemia is life-threatening then treat with:
- Glucose-insulin
- Sodium bicarb
- Kayexelate
- Dialysis
- Calcium (controversial: some say dangerous, others say not)
Hypokalemia
- Chronic intoxication
- Raise level to 3.5-4
- Acute intoxication
- Do not treat (likely that potassium level is rapidly rising)
Hypomagnesemia
- Treat with 1-2g over 10-20 min
- Monitor for resp depresion
- Avoid in pts with:
- Renal failure
- Bradydysrhythmias/conduction blocks
Disposition
- Admit for signs of toxicity or history of large ingested dose; admit to ICU if Fab given
- Discharge after 12hr observation if asymptomatic after accidental overdose
